Traditional Chinese medicine preparation for treating children bronchial asthma and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine preparation for treating children bronchial asthma and a preparation method thereof, belonging to the field of traditional Chinese medicine. The traditional Chinese medicine preparation is prepared from the following raw materials of active ingredients: leaf of delavey greenleaf elaeagnus, Chinese artichoke, negundo chastetree fruit, indian kalimeris herb, cannalike dona rhizome, anthriscus sylvestris, bergenia purpurascens, greenish lily flower, pinellia ternate, stephanotis, rattlesnake plantain, mallow leaf, mimosa pudica, gentiana sarcorrhiza, gynostemma pentaphyllum and cinnamomum glanduliferum (Wall.) nees; the compatibility among the selected medicinal materials of the traditional Chinese medicine preparation is appropriate, and the traditional Chinese medicine preparation accords with traditional Chinese medicine and modern medicine theories, has the efficacies of dispelling wind and eliminating dampness, clearing away heat and toxic materials, relieving cough and dyspnea, benefiting lung and promoting the circulation of Qi and clearing fire and calm nerves, is convenient to use, good in absorption effect and free of adverse effects and toxic and side effects. Through clinical verifications, the traditional Chinese medicine preparation has unexceptionable remission and treatment effects for children bronchial asthma, and is suitable for the application of clinical treatment and care of children bronchial asthma.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine preparation and a preparation method for treating children with bronchial asthma. Background technique [0002] Bronchial asthma, referred to as asthma, is one of the common respiratory diseases in pediatrics. At present, bronchial asthma is considered to be a chronic airway persistent inflammatory disease, in which many cells play an important role, such as lymphocytes, eosinophils, mast cells, etc., accompanied by significantly increased non-specific airway responses, and Airway hyperresponsiveness (BHR) is a multifactorial disease with the main clinical feature. [0003] The onset of bronchial asthma in children may vary due to different ages and different incentives. Most infantile bronchial asthma is induced by upper respiratory tract virus infection, and the onset is relatively slow, while bronchial asthma in children is mostly in...

AI Technical Summary

Problems solved by technology

[0004] If a patient with bronchial asthma has a severe acute attack, it may be fatal if the treatment is not timely. Patients with poorly controlled asthma will affect their daily work and daily life, reduce the quality of life, and bring economic burden and impact on family life. Negative impact, harm cannot be underestimated

[0005] The drugs currently used to treat children with bronchial asthma include leukotriene receptor antagonists, montelukast sodium, long-acting or sustained-release bronchiectasis and other drugs. Although these drugs have quick effects, they have certain side effects